BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17276663)

  • 21. Liquid and semisolid SLN dispersions for topical application: rheological characterization.
    Lippacher A; Müller RH; Mäder K
    Eur J Pharm Biopharm; 2004 Nov; 58(3):561-7. PubMed ID: 15451530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
    Souto EB; Anselmi C; Centini M; Müller RH
    Int J Pharm; 2005 May; 295(1-2):261-8. PubMed ID: 15848010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.
    Sakaeda T; Hirano K
    J Drug Target; 1998; 6(4):273-84. PubMed ID: 9894695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.
    Jores K; Mehnert W; Drechsler M; Bunjes H; Johann C; Mäder K
    J Control Release; 2004 Mar; 95(2):217-27. PubMed ID: 14980770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization.
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):541-4. PubMed ID: 16762843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation of solid lipid nanoparticles by microemulsion technique].
    Mao SR; Wang YZ; Ji HY; Bi DZ
    Yao Xue Xue Bao; 2003 Aug; 38(8):624-6. PubMed ID: 14628457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications.
    Kalariya M; Padhi BK; Chougule M; Misra A
    Indian J Exp Biol; 2005 Mar; 43(3):233-40. PubMed ID: 15816409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
    Hu LD; Tang X; Cui FD
    Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artemisia arborescens L essential oil-loaded solid lipid nanoparticles for potential agricultural application: preparation and characterization.
    Lai F; Wissing SA; Müller RH; Fadda AM
    AAPS PharmSciTech; 2006 Jan; 7(1):E2. PubMed ID: 16584150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ; Wu MZh; Yuan H; Zhang HH
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.
    Zimmermann E; Souto EB; Müller RH
    Pharmazie; 2005 Jul; 60(7):508-13. PubMed ID: 16076076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of particle size on oral absorption of silymarin-loaded solid lipid nanoparticles].
    He J; Hou SX; Feng JF; Cai BQ
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1651-3. PubMed ID: 16400939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
    Heiati H; Tawashi R; Phillips NC
    J Microencapsul; 1998; 15(2):173-84. PubMed ID: 9532523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
    Pedersen N; Hansen S; Heydenreich AV; Kristensen HG; Poulsen HS
    Eur J Pharm Biopharm; 2006 Feb; 62(2):155-62. PubMed ID: 16290122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.